NTL Healthcare announced that it was awarded the Minister of Health and Welfare Award for its contribution

to strengthening the competitiveness of the domestic medical device industry and expanding exports through

the development of AI new technology medical devices at the "2024 KIMES (Korea International Medical & Hospital Equipment Show)."

 

Through this award, NTL once again demonstrated the excellence and efficiency of its AI cervical cancer screening system,

CerviCARE AI, and was selected as an outstanding national research and development company.

Taehee Kim, CEO of NTL Healthcare, stated "As a specialized company in women's cancer Femtech,

we will continue to lead the development of the medical device industry and the eradication of cervical cancer."

 

During the four-day 2024 KIMES International Medical Device Exhibition held from March 14 to 17,

NTL signed contracts with medical device company in Poland and is in discussions with various European countries,

including Bulgaria, for the supply of the AI cervical cancer screening system, CerviCARE AI.

 

CerviCARE AI analyzes captured cervical images within 5 seconds ⁽¹⁾, distinguishing between normal, abnormal results

to support clinical decisions for medical professionals. It has been recognized for its excellence and efficiency

with a 98% sensitivity and 95.5% specificity ⁽²⁾ in high-grade cervical lesion analysis. Also, it not only distinguishes

cervical morphological abnormalities but also has a remote diagnosis system that can collaborate with gynecology oncologists worldwide,

expanding its overseas supply chain, particularly focusing on developing countries with relatively vulnerable medical infrastructure.

 

Through its participation in KIMES, NTL has achieved visible results and expects to expand its market to Europe, Taiwan, the Philippines, and Japan

in addition to Vietnam, Mongolia, Thailand, and Costa Rica where the system is already supplied.

 

 

 

Ref: 1) Test Report, Standard Bank, 2023

Ref: 2) Scientific Reports, 2024